Innovative Dual-Action Design for Rapid Occlusion*
Radiopaque marker band
Radiopaque Marker Bands for accurate placement and visualization
Proximal nitinol fi ber segment Proximal nitinol fi ber segment
designed to stabilize the membrane and promote thrombus formation
Occlusion membrane
Occlusion membrane supports rapid occlusion and limits recanalization
Radiopaque marker band
Distal nitinol fi ber segment
Distal nitinol fi ber segment designed to limit migration and promote thrombus formation
Radiopaque marker band
* In an arterial ovine Good Laboratory Practice (GLP) study with devices implanted according to labeled vessel diameters, full occlusion at 10 minutes was achieved with all Caterpillar™ and Caterpillar™ Micro Arterial Embolization Devices (14/14). Full occlusion defi ned as no perfusion – no antegrade fl ow beyond point of occlusion. Based on histopathology in an arterial ovine GLP study, all Caterpillar™ Arterial Embolization Devices had similar recanalization rates to control devices. Placement accuracy and track forces were measured through pre-clinical bench studies using either an anatomical splenic artery or right gastric artery model.
The Caterpillar™ and Caterpillar™ Micro Arterial Embolization Devices are indicated for arterial embolization in the peripheral vasculature. The devices are contraindicated for use in vessels subject to cyclic bending, such as locomotive joints or muscle beds. Please consult product labels and instructions for use for indication, contraindications, hazards, warnings, and precautions.
bd.com BD, Tempe, AZ, USA, 1 800 321 4254
© 2021 BD. BD, the BD Logo, and Caterpillar are trademarks of Becton, Dickinson and Company or an affiliate. All other trademarks are property of their respective owners. © 2021. All Rights Reserved. BD-21051
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40
